Moreover, the inhibition of CCR1 was associated with impairment of osteoclastogenesis and OC-induced tumor cell proliferation in vitro, suggesting that the MIP-1α/CCR1 pathway is an important target in MM bone disease [35]. This evidence concerns the gene CCL3 and Miyoshi myopathy.